Patents by Inventor Andreia Chagas Munderloh

Andreia Chagas Munderloh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240024017
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Application
    Filed: June 22, 2023
    Publication date: January 25, 2024
    Inventors: Kester Julian Batchelor, Anh Tri La, Andreia Chagas Munderloh
  • Patent number: 11751933
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: September 12, 2023
    Assignee: Gyrus ACMI, Inc.
    Inventors: Kester Julian Batchelor, Anh Tri La, Andreia Chagas Munderloh
  • Publication number: 20220039855
    Abstract: A forceps system for sealing a blood vessel can include a first jaw and an opposing second jaw. At least one of the first and second jaws includes at least a first electrode having first and second electrode portions that are laterally separated to permit electrical isolation between the first and second electrode portions, and the first and second electrode portions are independently addressable to permit individual testing by the first and second electrodes portions of a blood vessel characteristic. This can help permit individual testing of each side of a target seal region of the blood vessel.
    Type: Application
    Filed: August 3, 2021
    Publication date: February 10, 2022
    Inventors: Kester Julian Batchelor, Anh Tri La, Andreia Chagas Munderloh
  • Publication number: 20200352638
    Abstract: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 12, 2020
    Inventors: Kester Julian Batchelor, Anh Tri La, Andreia Chagas Munderloh